Future Science Group
Browse

Infographic. Immune-related adverse events with PD-1 versus PD-L1 inhibitors: a meta-analysis of 8730 patients from clinical trials

Download (3.05 MB)
figure
posted on 2021-05-20, 09:31 authored by Guru P. Sonpavde, Petros Grivas, Daniel Hennessy, Yushun Lin, Jay D Hunt
Infographic summary of the article ‘ Immune-related adverse events with PD-1 versus PD-L1 inhibitors: a meta-analysis of 8730 patients from clinical trials’

Funding

EMD Serono, Inc, MA, USA; an affiliate of Merck KGaA, Darmstadt, Germany

History

Usage metrics

    Future Oncology

    Categories

    Keywords

    anti-PD-1anti-PD-L1immune-related adverse eventsimmune checkpoint inhibitormeta-analysisCancer Therapy (excl. Chemotherapy and Radiation Therapy)

    Licence

    CC BY-NC-ND 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC